Cronos Group Inc. CRON
3.45 USD +0.04 (+1.17%)
At closeNov 12, 2026, 5:39 AM EST
3.36 -0.09 -2.57%
Pre-market · Nov 12, 5:39 AM ET
3.36 Day range 3.48
2.28 52-week range 3.91
- YTD
- +31.18%
- 1 year
- +36.90%
News
seekingalpha.com One Regulator Could Soon Unlock Altria And Cronos' Cannabis Fortune Altria remains fundamentally well-positioned for U.S. cannabis entry, primarily through its 42% stake in Cronos Group. MO's core tobacco business continues to generate robust cash flow, with Q2 2026…
seekingalpha.com Cronos Group Inc. (CRON:CA) Q3 2026 Earnings Call Transcript Cronos Group Inc. (CRON:CA) Q3 2026 Earnings Call Transcript
defenseworld.net Cronos Group (NASDAQ:CRON) Hits New 52-Week High After Strong Earnings Shares of Cronos Group Inc. (NASDAQ: CRON - Get Free Report) hit a new 52-week high during mid-day trading on Thursday following a better than expected earnings announcement. The company traded as…
marketbeat.com Cronos Group Q3 Earnings Call Highlights Cronos Group NASDAQ: CRON reported record third-quarter revenue, gross profit and adjusted EBITDA as cannabis sales grew in Israel, Canada and Germany, while executives outlined plans to expand in…
zacks.com Cronos Group (CRON) Q3 Earnings and Revenues Beat Estimates Cronos Group (CRON) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.07 per share a year ago.
benzinga.com Cronos Group Q3 EPS $0.04 Beats $0.03 Estimate, Sales $63.450M Beat $49.467M Estimate Cronos Group (TSX:CRON) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $0.03 by 33.33 percent. This is a 42.86 percent decrease over earnings of $0.07 per…
globenewswire.com Cronos Group Reports 2026 Third Quarter Results Organically achieved record net revenue, gross profit, and Adjusted EBITDA while reducing share count
benzinga.com This Electra Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday Analysts initiated coverage on NHP (Outperform, $20), OIG (Buy, $13), ETRA (Overweight), AHR (Strong Buy, $62).
benzinga.com Zuanic & Associates Initiates Coverage On Cronos Group with Overweight Rating Zuanic & Associates analyst Pablo Zuanic initiates coverage on Cronos Group (NASDAQ:CRON) with a Overweight rating.